相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors
Vicky Mengfei Qin et al.
FRONTIERS IN IMMUNOLOGY (2022)
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma
Michael D. Jain et al.
BLOOD (2021)
Radiotherapy to Enhance Chimeric Antigen Receptor T-Cell Therapeutic Efficacy in Solid Tumors A Narrative Review
Franziska Hauth et al.
JAMA ONCOLOGY (2021)
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
Erin A. Dean et al.
BLOOD ADVANCES (2020)
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S. Abramson et al.
LANCET (2020)
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
Frederick L. Locke et al.
BLOOD ADVANCES (2020)
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
Laetitia Vercellino et al.
BLOOD ADVANCES (2020)
Evaluating CAR-T Cell Therapy in a Hypoxic 3D Tumor Model
Yuta Ando et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Hypoxia Selectively Impairs CAR-T Cells In Vitro
Robert Berahovich et al.
CANCERS (2019)
Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL
Kavita Bhalla et al.
SCIENTIFIC REPORTS (2018)
The Validation Path of Hypoxia PET Imaging: Focus on Brain Tumours
Natale Quartuccio et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry
Paola Mapelli et al.
CURRENT RADIOPHARMACEUTICALS (2018)
First Evaluation of PET-Based Human Biodistribution and Dosimetry of 18F-FAZA, a Tracer for Imaging Tumor Hypoxia
Annarita Savi et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hypoxia Enhances Immunosuppression by Inhibiting CD4(+) Effector T Cell Function and Promoting Treg Activity
Astrid M. Westendorf et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Omkar U. Kawalekar et al.
IMMUNITY (2016)
Prognostic value of 18F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer
Tsuneo Saga et al.
CANCER SCIENCE (2015)
Assessment of hypoxic subvolumes in laryngeal cancer with 18F-fluoroazomycinarabinoside (18F-FAZA)-PET/CT scanning and immunohistochemistry
Leonie Bruine de Bruin et al.
RADIOTHERAPY AND ONCOLOGY (2015)
GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α
J. Chiche et al.
LEUKEMIA (2015)
A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy
Stephanie Servagi-Vernat et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: Possible implications for radiotherapy treatment planning strategies
Vikram R. Bollineni et al.
RADIOTHERAPY AND ONCOLOGY (2014)
PET Imaging of Tumor Hypoxia Using 18F-Fluoroazomycin Arabinoside in Stage III-IV Non-Small Cell Lung Cancer Patients
Vikram R. Bollineni et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL
Marco A. Hernandez-Luna et al.
LEUKEMIA & LYMPHOMA (2013)
FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial
Lise Sakso Mortensen et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics
Edward E. Graves et al.
CLINICAL CANCER RESEARCH (2010)
Initial results of hypoxia imaging using 1-α-D-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA)
Ernst J. Postema et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Cutting edge:: Hypoxia-inducible factor 1α and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes
Dmitriy Lukashev et al.
JOURNAL OF IMMUNOLOGY (2006)
分享论文
